JP2023550079A5 - - Google Patents
Info
- Publication number
- JP2023550079A5 JP2023550079A5 JP2023529034A JP2023529034A JP2023550079A5 JP 2023550079 A5 JP2023550079 A5 JP 2023550079A5 JP 2023529034 A JP2023529034 A JP 2023529034A JP 2023529034 A JP2023529034 A JP 2023529034A JP 2023550079 A5 JP2023550079 A5 JP 2023550079A5
- Authority
- JP
- Japan
- Prior art keywords
- rilpivirine
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical composition
- hyaluronidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063114997P | 2020-11-17 | 2020-11-17 | |
| US63/114,997 | 2020-11-17 | ||
| PCT/US2021/072453 WO2022109555A1 (en) | 2020-11-17 | 2021-11-17 | Treatment or prevention of hiv infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550079A JP2023550079A (ja) | 2023-11-30 |
| JP2023550079A5 true JP2023550079A5 (cg-RX-API-DMAC7.html) | 2024-11-26 |
Family
ID=86558047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023529034A Pending JP2023550079A (ja) | 2020-11-17 | 2021-11-17 | Ｈｉｖ感染症の治療又は予防 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230405001A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4247342A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023550079A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230110548A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116437923A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021383922A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196799A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302856A (cg-RX-API-DMAC7.html) |
| JO (1) | JOP20230108A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023005758A (cg-RX-API-DMAC7.html) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ542873A (en) * | 2003-03-05 | 2008-07-31 | Halozyme Inc | Soluble, neutral-active hyaluronidase activity glycoprotein (sHASEGP) that is produced with high yield in a mammalian expression system by introducing nucleic acids that lack a narrow region encoding amino acids in the carboxy terminus of the human PH20 cDNA |
-
2021
- 2021-11-17 MX MX2023005758A patent/MX2023005758A/es unknown
- 2021-11-17 CN CN202180077125.2A patent/CN116437923A/zh active Pending
- 2021-11-17 EP EP21824738.5A patent/EP4247342A1/en active Pending
- 2021-11-17 JP JP2023529034A patent/JP2023550079A/ja active Pending
- 2021-11-17 KR KR1020237020228A patent/KR20230110548A/ko active Pending
- 2021-11-17 US US18/037,204 patent/US20230405001A1/en active Pending
- 2021-11-17 IL IL302856A patent/IL302856A/en unknown
- 2021-11-17 AU AU2021383922A patent/AU2021383922A1/en active Pending
- 2021-11-17 CA CA3196799A patent/CA3196799A1/en active Pending
-
2023
- 2023-05-16 JO JOJO/P/2023/0108A patent/JOP20230108A1/ar unknown